Drug Labels Can Provide 'Specific Intent' For Inducement
Induced infringement under Section 271(b) of the Patent Act is particularly relevant in pharmaceutical litigation where method-of-use claims are an important component of patent protection. Generic pharmaceutical companies may attempt to...To view the full article, register now.
Already a subscriber? Click here to view full article